Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study reveals replication sites of emerging pig disease
Research could be used in the development of vaccines.

Confirms structures are similar to those in same virus family

The sites within the cell where porcine deltacoronavirus (PDCoV) makes new copies of itself during replication have been uncovered, in a study carried out at The Pirbright Institute.

According to a statement, the research confirmed that PDCoV uses the host cell’s machinery to create two different structures that form the replication organelle. These structures are very similar to those created by infectious bronchitis virus (IBV), a Gammacoronavirus that causes debilitating disease in chickens.

Using electron microscopy, Pirbright researchers where able to confirm their prediction that the structures formed by PDCoV when replicating would be comparable to those formed in replication sites in the other three genera of the coronavirus family – which have already been well defined.

This evidence suggests that there are further similarities across the family which could be targeted and used in the development of vaccines, antivirals and coronavirus resistance breeding programmes.

Head of Pirbright’s nidovirus-cell interactions group Dr Helena Maier said: “Imaging porcine deltacoronavirus during host cell infection provides an important insight into the replication mechanisms used by this group of viruses.

“This is particularly important since other Deltacoronaviruses cannot be adapted to cell culture, which makes it very challenging to study how they replicate and interact with the host cellular machinery.”

This study will inform the group’s further work in understanding how the coronavirus family interacts with host cells, and could lead to the development of broad-spectrum control methods to tackle the diseases caused by this virus family.

 

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.